Medtronic plc (MDT)
| Market Cap | 108.04B |
| Revenue (ttm) | 32.32B |
| Net Income (ttm) | 4.20B |
| Shares Out | 1.33B |
| EPS (ttm) | 3.14 |
| PE Ratio | 25.91 |
| Forward PE | 15.58 |
| Dividend | $2.80 (3.44%) |
| Ex-Dividend Date | Jun 28, 2024 |
| Volume | 11,185,549 |
| Open | 80.72 |
| Previous Close | 80.60 |
| Day's Range | 80.62 - 81.48 |
| 52-Week Range | 68.84 - 91.00 |
| Beta | 0.80 |
| Analysts | Hold |
| Price Target | 93.00 (+14.29%) |
| Earnings Date | May 23, 2024 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2023, Medtronic's revenue was $31.23 billion, a decrease of -1.45% compared to the previous year's $31.69 billion. Earnings were $3.76 billion, a decrease of -25.42%.
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for MDT stock is "Hold." The 12-month stock price forecast is $93.0, which is an increase of 14.29% from the latest price.
News
Medtronic announces pricing of €3.0 billion of senior notes
DUBLIN , May 29, 2024 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has priced an offering (the "Offering") of €...
Medtronic Q4 earnings: ‘we're optimistic about fiscal 2025'
Medtronic PLC (NYSE: MDT) is in focus on Thursday after reporting market-beating financial results for its fourth quarter. Medtronic issues in-line guidance The stock is flat at writing because $MDT ...
Medtronic's stock rises after earnings beat expectations and the dividend was raised
Shares of Medtronic PLC MDT, +0.69% rallied 1.3% in premarket trading Thursday, after the medical device and therapies company reported fiscal fourth-quarter profit and revenue that rose above expecta...
Medtronic beats quarterly profit estimates on medical devices strength
Health tech firm Medtronic beat Wall Street estimates for quarterly profit on Thursday, aided by a post-pandemic pickup in surgical volumes at hospitals that boosted demand for its medical devices.
Medtronic reports full year and fourth quarter fiscal 2024 financial results; announces dividend increase
Broad-based, durable growth across the company, including Cranial & Spinal Technologies, Diabetes, Cardiac Pacing, Surgical, and Structural Heart; gaining momentum as company enters new product cycles...
Will Medtronic Stock See Higher Levels Post Q4 Results After 5% Gains This Year?
Medtronic (NYSE: MDT) is scheduled to report its fiscal 2024 fourth-quarter results on Thursday, May 23 (fiscal ends in April). We expect Medtronic Medtronic stock to trade sideways post-Q4 results an...
Medtronic Affera™ Mapping and Ablation System with Sphere-9™ Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment
HRS late breaking data: SPHERE Per-AF trial demonstrates novel all-in-one system delivers exceptional results, plus increased efficiency and improved quality of life DUBLIN and BOSTON, May 17, 2024 /P...
Late-breaking data show reliable performance of small-diameter defibrillation lead, the Medtronic OmniaSecure™
Global LEADR clinical trial meets safety and effectiveness objectives; results presented at Heart Rhythm 2024 and simultaneously published in Heart Rhythm DUBLIN and BOSTON , May 17, 2024 /PRNewswire/...
Medtronic to announce financial results for its fourth quarter and full fiscal year 2024
DUBLIN , May 9, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal ye...
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
Arecor Therapeutics plc (“Arecor” or the “Company”) ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund Arecor...
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain DUBLIN , April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare t...
Americans favor quality over quantity in pursuit of longevity
According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues DUBLIN , April 17, 2024...
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, pre...
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy DUBLIN , April 10, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a g...
ModMed & Medtronic Collaborate to Drive Efficiencies in Documenting Colonoscopies Using AI
BOCA RATON, Fla.--(BUSINESS WIRE)--ModMed® announced it will collaborate with Medtronic to enhance documentation of polyp detection by using AI capabilities of the GI Genius system.
BioCT Welcomes Mike Stow of Medtronic to Its Board of Directors
NEW HAVEN, Conn.--(BUSINESS WIRE)--BioCT, Connecticut's life sciences trade association, is thrilled to announce the appointment of Mike Stow, Vice President of Global Marketing for Robotic Surgical T...
OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic Rhinosinusitis
BOSTON--(BUSINESS WIRE)--OM1, the leading AI and insights-driven technology and data company specializing in personalized medicine, evidence generation, and real-world evidence, today announced result...
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System DUBLIN and BERLIN , April 8, 202...
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
New data from largest head-to-head randomized control TAVR trial demonstrates non-inferior clinical outcomes and superior valve performance for Evolut TAVR compared to Sapien™ at one year DUBLIN and A...
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities...
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access DUBLIN , March 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...
Viz.ai and Medtronic Collaborate to Improve Post-Acute Stroke Patient Care in the United States
SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, Inc., the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic collaboration with Medtronic to improve th...
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
Medtronic moves for patent infringement litigation to resume DUBLIN , March 21, 2024 /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in healthcare technology, today announced that the Patent ...
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management
New data presented at ATTD demonstrates the system's ability to help individuals with type 1 diabetes exceed international targets on outcome measures DUBLIN and FLORENCE, Italy , March 9, 2024 /PRNew...